Physician profile
John L Turner
NPI 1497746150
$1,025.28
in general payments reported to CMS, 2019-2025
19 companies · $24.61 in 2025
The $24.61 reported for 2025 was less than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $519 · 2020: $268 · 2021: $71.37 · 2022: $78.47 · 2023: $63.76 · 2025: $24.61.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $88.37.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $88.37 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $216.73 | 2019-2021 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $184.02 | 2019-2023 | Xifaxan |
| Amgen INC. | $103.33 | 2019 | |
| Radius Health, INC. | $88.05 | 2019-2020 | |
| Astrazeneca Pharmaceuticals LP | $52.87 | 2019-2020 | |
| Teva Pharmaceuticals USA, INC. | $52.61 | 2019 | |
| Pfizer INC. | $44.04 | 2019 | |
| Endo Pharmaceuticals INC. | $43.34 | 2020-2021 | |
| Horizon Therapeutics Plc | $36.41 | 2020-2021 | |
| Sobi, INC | $31.77 | 2023 | |
| Redhill Biopharma INC. | $24.97 | 2020 | |
| Lilly USA, LLC | $24.61 | 2025 | Zepbound |
| Janssen Pharmaceuticals, INC | $19.72 | 2020 | |
| Ani Pharmaceuticals, INC. | $18.58 | 2023 | Purified Cortrophin Gel |
| Valeritas, INC. | $18.36 | 2019 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sanofi-Aventis U.S. LLC | $17.60 | 2020 | |
| Bausch Health US, LLC | $17.43 | 2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $16.09 | 2020 | |
| Ibsa Pharma INC. | $14.75 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Turner listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.